Gastrointestinal factor .ulmonary clearance of insulin and a normal or slightly elevated glucose levels were found following oral glucose tolerance tests. 3 The aim of the present study was to examine the possibility that gastrointestinal, hepatic or pulmonary factors may play a role in the metabolic alterations in children with congenital heart disease with and without heart failure. In an attempt to clarify the role of the gastrointestinal tract, glucose and insulin levels were compared following oral and intravenous glucose tolerance tests (GTT) . To assess the role of the liver, simultaneous hepatic venous and systemic arterial glucose and insulin levels were compared following i.v. GTT. The role of the lung as a possible insulin clearing organ was investigated by comparing insulin levels in pulmiioniary arterial anid aortic blood samples during ix. GTT.
Methods
Glucose tolerance tests (GTT) were performed on 54 patients raniging in age from 12 days to 16 years. In 36 of the patients oral GTT was performed. In 20, both oral and i.v. GTT were performed. In 17, only i.v. GTT was done. In four of the patients, oral GTT was repeated three times to coincide with an observed increase in the intensity of the cyanosis or an improvement of the congestive heart failure.
The oral tests were carried out both on the wards and in the outpatient department of the Bronx Municipal Hospital Center. Intravenous GTT were performed during cardiac catheterization. Children with a family history of diabetes were excluded. For the purpose of the study, a positive family history was taken to mean diabetes mellitus in a parent or grandparent. The diagnosis of congestive heart failure (CHF) was based on the presence of several of the following clinical signs and symptoms: cardiac enlargement, tachycardia, decreased peripheral pulsation, growth failure, sweating, tachypnea, dyspnea with effort, cough, rales, and hepatomegaly. All children with CHF required medical management for their heart failure and were treated with digoxin. Whenever possible a glucose tolerance test was performed before institution of the drug. The patients were classified clinically into four groups (table 1) :
Group I consisted of 16 children who represented the control group. Ten were healthy normal children without significant cardiac involvement. The six children in this group who were subjected to cardiac catheterization either had normal hemodynamics or small left-to-right shunts. All were between the 3rd and 90th percentile of the Stuart growth chart for weight and height.
Group II consisted of 9 noncyanotic children with significant left-to-right shunts but uncomplicated by congestive heart failure. Five were catheterized. All were between the 10th and 97th percentile for weight. Group IV consisted of 12 children with various types of cyanotic heart disease and diminished pulmonary flow, but without evidence of heart failure. Nine were catheterized. All were between the 3rd and 50th percentile for weight.
The children had been eating as usual with no missed meals during the previous 3 days. Oral glucose tolerance tests were performed after an overnight fast. During the first months of life, fasting was limited to 6-8 hours. In subjects older than 3 months, fasting was for 10-14 hours. Glucose was given as a 25% solution, chilled and flavored. The doses used were 2.5 g/kg for infants 0-18 months; 2.0 g/kg for 18 months to 3 years; 1.75 g/kg for 3-12 years of age; and 1.25 g/kg for children over the age of 12 years. 4 Blood samples were obtained before and Xi, 1, 2, 3, and 4 hours after the glucose administration. In infants, capillary blood was obtained from the heel. In the older children a scalp vein needle was inserted into an antecubital vein for blood sampling. A very slow infusion of normal saline was given to prevent clotting in the catheter throughout the 4-hour period of the test. While no vigorous physical activity was permitted in these children during the procedure, a quiet state was not always achieved. Most infants cried while capillary blood sampling specimens were obtained.
Blood for glucose and insulin determination was placed immediately in heparinized, sterile plastic tubes standing in ice water, then centrifuged in the cold. The serum collected was kept frozen at -19°C until analyzed. Concentrations of glucose were measured by the enzyme for true glucose determination using 0.1 ml of serum. 5 Radioimmunoassay determination of plasma insulin was performed by a modified method of Yalow and Berson. 6 The plasma insulin levels in samples obtained simultaneously from the hepatic vein and aorta, or from the pulmonary artery and the aorta, were measured at the same time.
Intravenous glucose tolerance tests were done in 17 children during cardiac catheterization. Six children were from group I, five children from group III, and six from group IV. None of these children received general anesthesia. No premedication was given to infants less than 3 months of age. Older children received 1 mg/kg of meperidine hydrochloride (Demerol) and 1 mg/kg of hydroxyzine (Vistaril) by the im route. The inguinal region was infiltrated with 0.5- A correlation between the changes in plasma glucose as well as for insulin in relation to time was derived by employing a coefficient (K) of glucose assimilation for arterial (Ka) and for hepatic venous (Kh) blood, respectively. After glucose mixed through the vascular space during the first 0-15 min, the glucose concentration falls in a curve approximating a negative exponential function.8 Several methods have been proposed for analyzing this curve. All are based on the assumption that it is a semilogarithmic curve. We have used the formula:
(log C -log C) log 10
Where C = concentration of glucose in mg per 100 ml of plasma, t2 = 60 min, t1 = 15 min, n = number of samples obtained. The value K obtained was expressed as mg%/min. The relative impermeability of cell membranes to glucose throughout the body makes it possible to calculate the diffusion space of glucose which prevails during the first few minutes following rapid intravenous injection of glucose. This is feasible since the rapid rise in blood glucose is insufficient in the first few minutes to induce a hypersecretion of insulin.
By this method the extracellular glucose compartment in the control patients has been found to be very similar to that obtained with sodium thiocyanate or other technics. 9 The extracellular glucose compartment (diffusion space) (Vg) was determined by using the formula Vg-(A Q-C in which Q2 was the quantity of glucose introduced, A was the extrapolation of the assimilation line to time 0, and Co was the initial glucose concentration9 (see fig. 4 ).
Results

Oral Glucose Tolerance Tests
The mean plasma glucose level was higher than the control in children with uncomplicated CHD (P < 0.025) at 1 and 2 -hours and in children with congestive heart failure (P < 0.005, P < 0.02, and P < 0.005) at X, 1, and 2 hours, respectively (tables 2, 3; figs. 1, 2) . The mean plasma glucose levels in children with cyanosis (CY) were higher than in the control at M through 3 hours but were not statistically significant. The mean plasma glucose levels in CY were lower than the mean glucose levels in children with CHF at 2, 1, and 2 hours. As the blood glucose rose from the fasting level, plasma insulin increased steadily to a peak value of 45.6 + 7.2 in the control at M hour, 31.9 ± 6 in the uncomplicated group at 1 hour, 12± 2.8 in those with CHF at 1 hour, and 67.9 ± 11.6 ,uU/ml in the CY group at 1 hour. The net gain of plasma insulin in the uncomplicated group was lower than control at 3 hour (P<0.05) (fig. 2) . However, in the CHF group the net gain insulin level was much lower than control at X hour (P<0.001), at 1 hour (P<0.001), and at 2 hours (P<0.005), respectively ( fig. 2) . On the other hand, in the CY group the net gain insulin level was higher than control at X, 1, and 2 hours but was statistically significant only at 1 hour (P < 0.05). The lowest recorded peak plasma insulin level was 2.5 ,uU/ml in children in CHF, and the highest level of 134 ,uU/ml was seen in the CY group I+ S.E. Mean net gain of plasma concentration (+ sE) of insulin in response to oral and i.v. glucose tolerance tests in control, cyanotic, uncomplicated congenital heart disease, and in children with congestive heart failure.
in one case at X and in a second case at 1 hour. The total net gain of plasma insulin released throughout the GTT in the various groups was calculated by planimetry from the total area under the insulin curve obtained following oral GTT. Taking the total net gain of plasma insulin in the control group as 100%, the net gain in the CHF group was 20%, in the uncomplicated group 65%, and in the CY group 142%, respectively (table 4).
Intravenous Glucose Tolerance Tests
The glucose assimilation coefficients of the arterial (Ka) and the hepatic venous blood (Kh) were 1.84 and 1.34% in the control group; 0.94 and 0.86% in the CHF group; and 1.50 and 1.36% in the CY group, respectively Figure 4 Relationship between body weight (kg) and glucose diffusion space (extracellular compartment) in control, cyanotic, and congestive heart failure. Note the twofold increase in this space in children with congestive heart failure.
Discussion
Several abnormalities of glucose and insulin metabolism were observed in this study. Infants in congestive heart failure had abnormally high glucose levels following oral GTT ( fig. 1 ). Plasma glucose levels up to 310 mg/100 ml were observed. The result of our studies indicated that suppression of insulin release served as a contributing mechanism for this abnormality ( fig. 2 ). In the group of uncomplicated CHD with moderate left-toright shunts, slightly higher than normal levels of glucose and significantly lower than normal levels of insulin were observed ( figs. 1, 2, 6 ). These metabolic alterations could therefore be regarded either as a more sensitive index of Ciculation, Volume XLVI, August 1972 heart failure than the usual clinical criteria or as the direct result of left-to-right shunt. Our results from four control patients as well as other preliminary findings10 suggest that in addition to the known insulin-deactivating systems in the liver, kidney, muscle, and other tissues, a significant amount of insulin is cleared by the lung. The reduction of insulin across the lung in the control group was estimated at about 25% ( fig. 5 ). Furthermore, we observed a significant correlation between plasma insulin levels and pulmonary blood flow ( fig. 6 ), and this may provide a partial explanation for the abnormally low arterial insulin levels in patients with moderate and large left-to-right shunts as a result of Plasma insulin obtained and arrayed simultaneously from the pulmonary artery and aorta in a 9-year-old patient with insignificant cardiac lesion.
excessive clearance by the lung. Similarly, in the CY group, the elevation of arterial insulin level is due to the underclearance of insulin by the lung because of reduced pulmonary blood flow ( fig. 6 ). However, the plasma insulin levels in the aortic and hepatic venous blood following i.v. GTT were too small to allow a similar conclusion.
In patients with CHF the marked reduction in insulin level observed in the hepatic vein suggests therefore that mechanisms other than lung clearance are involved. Possible mechanisms may include reduction in the rate of incorporation of amino acid into insulin, excessive destruction of insulin by the liver, suppression of pancreatic release of insulin, or some combination of these factors. The rate of incorporation of labeled amino acid into insulin in the islet tissue was shown to be dependent on the amino acid concentration and the presence of oxygen.11 In the present study, the group with CHF had a mean extracellular compartment twice as large as that in the control group (fig. 4) Norepinephrine, which is found in excess in the plasma and urine of patients with congestive heart failure,13 may inhibit the release of insulin through its specific alphaadrenergic receptor effect.2' 14, 1; The important inhibitory control of insulin by the sympathetic nervous system had been demonstrated in cardiogenic shock,"' hypothermia,"7 pheochromocytoma,18 and most recently in congestive heart failure. 19 The possibility that protein-calorie deficiency alone may be an important factor in suppression of insulin release20-25 must also be considered. Such The reason for the significantly higher levels of insulin and glucose in the peripheral circulation following oral glucose load in children with cyanotic heart disease is unclear. Qp/Qs . 6 ). Contrary to the findings of increased insulin release following oral GTT, the intravenous GTT studies of the cyanotic group showed abnormally low levels of insulin in the hepatic vein ( fig. 2 ). These low levels were similar to those seen in the group with CHF ( fig. 2) 39 and glucose levels following oral GTT40 in individuals with heart disease have been reported previously. Very low fasting blood sugars were observed in three elderly patients with congestive heart failure.38 These patients, however, were in the terminal phase of their disease, and blood was obtained just before or during coma. All patients showed evidence of liver disease and unequivocal diffuse hepatic damage on histologic examination. Similar values were reported just before death in a group of newborn infants in congestive heart failure.39 Unlike the usual child in congestive heart failure, this group consisted of newborn infants with the hypoplastic left ventricle syndrome, known to die within the first few days of life, probably because of inadequate perfusion of blood to the myocardium and to other vital organs. Histologic studies of such infants4' also revealed hepatic necrosis which may have contributed to the development of hypoglycemia.
In CHF, fasting arterial insulin levels were higher, reached lower peaks than controls, and had a markedly reduced assimilation coefficient (Ki = 0.06) ( fig. 3) 
